Analysts’ Updated EPS Estimates for August 20th (ACIU, ADI, ALL, BILL, BRT, BWLP, CGS, COTY, CPRT, CRM)

Analysts’ updated eps estimates for Thursday, August 20th:

AC Immune (NASDAQ:ACIU) had its buy rating reiterated by analysts at BTIG Research. BTIG Research currently has a $8.00 price target on the stock.

Analog Devices (NASDAQ:ADI) was upgraded by analysts at Seaport Research Partners from a neutral rating to a buy rating. The firm currently has $425.00 price target on the stock.

Analog Devices (NASDAQ:ADI) had its buy rating reissued by analysts at TD Cowen. They currently have a $460.00 price target on the stock.

Allstate (NYSE:ALL) had its underperform rating reaffirmed by analysts at Keefe, Bruyette & Woods. They currently have a $250.00 target price on the stock, down from their previous target price of $255.00.

BILL (NYSE:BILL) had its buy rating reaffirmed by analysts at BTIG Research. They currently have a $60.00 target price on the stock.

BRT Apartments (NYSE:BRT) had its market outperform rating reaffirmed by analysts at Citizens Jmp. The firm currently has a $20.00 price target on the stock.

BW LPG (NYSE:BWLP) was upgraded by analysts at Clarkson Capital from a neutral rating to a buy rating.

Castings (LON:CGS) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 390 price target on the stock.

Coty (NYSE:COTY) was downgraded by analysts at Royal Bank Of Canada from an outperform rating to a sector perform rating. Royal Bank Of Canada currently has $3.00 target price on the stock.

Copart (NASDAQ:CPRT) had its equal weight rating reissued by analysts at Stephens. Stephens currently has a $35.00 target price on the stock.

Salesforce (NYSE:CRM) had its overweight rating reiterated by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $250.00 target price on the stock.

Salesforce (NYSE:CRM) had its buy rating reissued by analysts at Guggenheim. The firm currently has a $228.00 price target on the stock.

CleanTech Lithium (LON:CTL) had its speculative buy rating reissued by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 17 price target on the stock.

Estee Lauder Companies (NYSE:EL) had its neutral rating reaffirmed by analysts at B. Riley Financial, Inc.. The firm currently has a $100.00 target price on the stock, up from their previous target price of $85.00.

Etsy (NYSE:ETSY) was upgraded by analysts at Bank of America Corporation from a neutral rating to a buy rating. They currently have $95.00 price target on the stock, up from their previous price target of $88.00.

Figure Technology Solutions (NASDAQ:FIGR) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $55.00 price target on the stock.

Fluence Energy (NASDAQ:FLNC) was downgraded by analysts at Glj Research from a buy rating to a hold rating. Glj Research currently has $12.89 price target on the stock, down from their previous price target of $26.00.

Gerdau (NYSE:GGB) was downgraded by analysts at Bank of America Corporation from a buy rating to a neutral rating. They currently have $5.10 target price on the stock.

Alphabet (NASDAQ:GOOGL) had its buy rating reaffirmed by analysts at Rosenblatt Securities. They currently have a $410.00 target price on the stock.

Himalaya Shipping (NYSE:HSHP) was upgraded by analysts at Clarkson Capital from a neutral rating to a buy rating.

Incyte (NASDAQ:INCY) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $150.00 target price on the stock.

JD Sports Fashion (LON:JD) had its hold rating reiterated by analysts at Shore Capital Group Ltd. They currently have a GBX 75 target price on the stock.

Korro Bio (NASDAQ:KRRO) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $15.00 target price on the stock.

Neutron (NASDAQ:LIME) had its market outperform rating reissued by analysts at Citizens Jmp. They currently have a $45.00 price target on the stock.

Lowe’s Companies (NYSE:LOW) had its sector perform rating reaffirmed by analysts at Royal Bank Of Canada. They currently have a $231.00 price target on the stock.

Lowe’s Companies (NYSE:LOW) had its hold rating reaffirmed by analysts at TD Cowen. The firm currently has a $235.00 price target on the stock.

Lowe’s Companies (NYSE:LOW) had its overweight rating reiterated by analysts at KeyCorp. They currently have a $275.00 price target on the stock.

MFA Financial (NYSE:MFA) had its sector perform rating reissued by analysts at Royal Bank Of Canada. They currently have a $10.00 price target on the stock.

Merck & Co., Inc. (NYSE:MRK) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating. Morgan Stanley currently has $179.00 price target on the stock, up from their previous price target of $116.00.

Merck & Co., Inc. (NYSE:MRK) had its sector perform rating reaffirmed by analysts at Royal Bank Of Canada. The firm currently has a $150.00 target price on the stock, up from their previous target price of $142.00.

Marvell Technology (NASDAQ:MRVL) had its outperform rating reiterated by analysts at Royal Bank Of Canada. They currently have a $360.00 target price on the stock.

I-Mab (NASDAQ:NBP) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $9.00 price target on the stock.

Nordson (NASDAQ:NDSN) had its buy rating reiterated by analysts at DA Davidson. They currently have a $345.00 price target on the stock.

NVIDIA (NASDAQ:NVDA) had its outperform rating reiterated by analysts at Royal Bank Of Canada. The firm currently has a $300.00 price target on the stock.

Nvni Group (NASDAQ:NVNI) was downgraded by analysts at Maxim Group from a buy rating to a hold rating.

NexPoint Residential Trust (NYSE:NXRT) had its market perform rating reissued by analysts at Citizens Jmp.

Oxford Nanopore Technologies (LON:ONT) had its buy rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. Deutsche Bank Aktiengesellschaft currently has a GBX 195 target price on the stock.

Progressive (NYSE:PGR) was upgraded by analysts at Keefe, Bruyette & Woods from a market perform rating to an outperform rating. The firm currently has $250.00 price target on the stock, up from their previous price target of $226.00.

Pool (NASDAQ:POOL) had its overweight rating reissued by analysts at Stephens. Stephens currently has a $225.00 target price on the stock.

Sezzle (NASDAQ:SEZL) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $172.00 price target on the stock.

Seaport Therapeutics (NASDAQ:SPTX) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $50.00 price target on the stock.

Standex International (NYSE:SXI) had its buy rating reiterated by analysts at DA Davidson. DA Davidson currently has a $350.00 price target on the stock.

Target (NYSE:TGT) had its sector weight rating reissued by analysts at KeyCorp.

LON:TIN (LON:TIN) had its buy rating reiterated by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 151 target price on the stock.

TJX Companies (NYSE:TJX) had its buy rating reaffirmed by analysts at BTIG Research. They currently have a $190.00 target price on the stock.

TJX Companies (NYSE:TJX) had its accumulate rating reiterated by analysts at Gordon Haskett. The firm currently has a $155.00 price target on the stock.

Telix Pharmaceuticals (NASDAQ:TLX) had its outperform rating reiterated by analysts at Wedbush. Wedbush currently has a $22.00 target price on the stock.

Universal Health Services (NYSE:UHS) had its sector perform rating reaffirmed by analysts at Royal Bank Of Canada. They currently have a $183.00 target price on the stock.

Wolfspeed (NYSE:WOLF) had its hold rating reissued by analysts at TD Cowen. They currently have a $25.00 target price on the stock.

Zevra Therapeutics (NASDAQ:ZVRA) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $26.00 price target on the stock.

Receive News & Ratings for AC Immune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AC Immune and related companies with MarketBeat.com's FREE daily email newsletter.